English

Core Laboratories N.V.

ESEF

Report (type unavailable) · filed 2022-04-07

1 filing records in this dataset, filed from 2022-04-07 to 2022-04-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Segments

Watchlist

Latest fiscal year

Revenue

470 million USD

2021 · USD

Exact inputs and evidence

Revenue: 470252000 USD Source

Operating margin

10.64%

2021 · %

Exact inputs and evidence

Operating Income: 50020000 USD Source
Revenue: 470252000 USD Source

Operating cash flow

52.9 million USD

2021 · USD

Exact inputs and evidence

Operating Cash Flow: 52946000 USD Source

Free cash flow

39.4 million USD

2021 · USD

Exact inputs and evidence

Operating Cash Flow: 52946000 USD Source
Capital Expenditure: 13539000 USD Source

Cash and cash equivalents: 17.7 million USD 2021-12-31 Source
Exact value

17703000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-04-07.

Financial data available through: 2021-12-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2021-12-31
Operating income: 2 of 11 periods available· newest 2021-12-31
Net income: 2 of 11 periods available· newest 2021-12-31
Operating cash flow: 2 of 11 periods available· newest 2021-12-31
Capital expenditure: 2 of 11 periods available· newest 2021-12-31
Total assets: 2 of 11 periods available· newest 2021-12-31
Total liabilities: 2 of 11 periods available· newest 2021-12-31
Current assets: 2 of 11 periods available· newest 2021-12-31
Current liabilities: 2 of 11 periods available· newest 2021-12-31
Cash and cash equivalents: 2 of 11 periods available· newest 2021-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-3.5%

Prior period

USD 487.27 million

2020-01-01 – 2020-12-31
Current period

USD 470.25 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

470252000 − 487267000 = -17015000 USD

487267000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
470252000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Core Laboratories N.V. · 2021-12-31 Core Laboratories N.V. (esef:724500MDYY5VBSAF5W50) Year-over-year change in Revenue: -17015000 USD Concept: fundies:Revenue Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-09T10:38:39Z Snapshot: a6d90d4b49a51421669fee8cc686d1999beceda904c5505aad70d76fe9d73fa7 Dimensions: Consolidated View: https://fundies.io/companies/esef/724500MDYY5VBSAF5W50?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 470252000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8809678 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 Input fundies:Revenue: 487267000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8809953 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0
The citation records this snapshot. The page link may show a newer release later.
Net income
+158.7%

Prior period

USD 9.06 million

2020-01-01 – 2020-12-31
Current period

USD 23.44 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

23442000 − 9062000 = 14380000 USD

9062000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
23442000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Core Laboratories N.V. · 2021-12-31 Core Laboratories N.V. (esef:724500MDYY5VBSAF5W50) Year-over-year change in Net income: 14380000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-09T10:38:39Z Snapshot: a6d90d4b49a51421669fee8cc686d1999beceda904c5505aad70d76fe9d73fa7 Dimensions: Consolidated View: https://fundies.io/companies/esef/724500MDYY5VBSAF5W50?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 23442000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8822946 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 Input fundies:NetIncome: 9062000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8823354 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-29.7%

Prior period

USD 75.27 million

2020-01-01 – 2020-12-31
Current period

USD 52.95 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

52946000 − 75272000 = -22326000 USD

75272000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
52946000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Core Laboratories N.V. · 2021-12-31 Core Laboratories N.V. (esef:724500MDYY5VBSAF5W50) Year-over-year change in Operating cash flow: -22326000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-09T10:38:39Z Snapshot: a6d90d4b49a51421669fee8cc686d1999beceda904c5505aad70d76fe9d73fa7 Dimensions: Consolidated View: https://fundies.io/companies/esef/724500MDYY5VBSAF5W50?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 52946000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8944954 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 Input fundies:OperatingCashFlow: 75272000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8945259 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+14%

Prior period

USD 11.88 million

2020-01-01 – 2020-12-31
Current period

USD 13.54 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

13539000 − 11880000 = 1659000 USD

11880000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
13539000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Core Laboratories N.V. · 2021-12-31 Core Laboratories N.V. (esef:724500MDYY5VBSAF5W50) Year-over-year change in Capital expenditure: 1659000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-09T10:38:39Z Snapshot: a6d90d4b49a51421669fee8cc686d1999beceda904c5505aad70d76fe9d73fa7 Dimensions: Consolidated View: https://fundies.io/companies/esef/724500MDYY5VBSAF5W50?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 13539000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8945928 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 Input fundies:CapitalExpenditure: 11880000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8946365 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

Revenue USD 470.25 million 100% of revenue
Operating costs Derived USD 420.23 million 89% of revenue
Operating income USD 50.02 million 11% of revenue
Tax, interest and other Derived USD 26.58 million 5.7% of revenue
Net income USD 23.44 million 5% of revenue

Cash

Operating cash flow USD 52.95 million 11% of revenue
Capital expenditure USD 13.54 million 2.9% of revenue
Free cash flow Derived USD 39.41 million 8.4% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 92%
2021 89%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	487267000	447203000 Derived	40064000	31002000 Derived	9062000	63392000 Derived	Source 2020-01-01 – 2020-12-31: 487267000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 40064000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 9062000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 75272000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 11880000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	470252000	420232000 Derived	50020000	26578000 Derived	23442000	39407000 Derived	Source 2021-01-01 – 2021-12-31: 470252000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 50020000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 23442000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 52946000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 13539000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 470.3M 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	487267000	Revenue: 487267000 Open source
20212021-12-31	Revenue	470252000	Revenue: 470252000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-3.5% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 487267000 Open source
20212021-12-31	Year over year	-3.5%	Revenue: 470252000 Open source Revenue: 487267000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 10.6% 2021

Net margin 5% 2021

Free cash flow margin 8.4% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	8.2%	Operating Income: 40064000 Open source Revenue: 487267000 Open source
20212021-12-31	Operating margin	10.6%	Operating Income: 50020000 Open source Revenue: 470252000 Open source
20202020-12-31	Net margin	1.9%	Net Income: 9062000 Open source Revenue: 487267000 Open source
20212021-12-31	Net margin	5%	Net Income: 23442000 Open source Revenue: 470252000 Open source
20202020-12-31	Free cash flow margin	13%	Revenue: 487267000 Open source Operating Cash Flow: 75272000 Open source Capital Expenditure: 11880000 Open source
20212021-12-31	Free cash flow margin	8.4%	Revenue: 470252000 Open source Operating Cash Flow: 52946000 Open source Capital Expenditure: 13539000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 52.9M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	75272000	Operating Cash Flow: 75272000 Open source
20212021-12-31	Operating cash flow	52946000	Operating Cash Flow: 52946000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 39.4M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	63392000	Operating Cash Flow: 75272000 Open source Capital Expenditure: 11880000 Open source
20212021-12-31	Free cash flow	39407000	Operating Cash Flow: 52946000 Open source Capital Expenditure: 13539000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

56.1% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	67%	Total Liabilities: 505887000 Open source Total Assets: 755311000 Open source
20212021-12-31	Liabilities / assets	56.1%	Total Liabilities: 432066000 Open source Total Assets: 769503000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.27× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	2.04×	Current Assets: 191557000 Open source Current Liabilities: 93999000 Open source
20212021-12-31	Current assets / current liabilities	2.27×	Current Assets: 216373000 Open source Current Liabilities: 95348000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	USD 9.06 million Exact value Exact value: 9062000 USD 2020-01-01 – 2020-12-31: 9062000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Core Laboratories N.V. · 2020-12-31 Core Laboratories N.V. (esef:724500MDYY5VBSAF5W50) Net Income: 9062000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-09T10:38:39Z Snapshot: a6d90d4b49a51421669fee8cc686d1999beceda904c5505aad70d76fe9d73fa7 Dimensions: Consolidated View: https://fundies.io/companies/esef/724500MDYY5VBSAF5W50/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 9062000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8823354 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 The citation records this snapshot. The page link may show a newer release later.	USD 75.27 million Exact value Exact value: 75272000 USD 2020-01-01 – 2020-12-31: 75272000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Core Laboratories N.V. · 2020-12-31 Core Laboratories N.V. (esef:724500MDYY5VBSAF5W50) Operating Cash Flow: 75272000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-09T10:38:39Z Snapshot: a6d90d4b49a51421669fee8cc686d1999beceda904c5505aad70d76fe9d73fa7 Dimensions: Consolidated View: https://fundies.io/companies/esef/724500MDYY5VBSAF5W50/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 75272000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8945259 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 The citation records this snapshot. The page link may show a newer release later.	USD 11.88 million Exact value Exact value: 11880000 USD 2020-01-01 – 2020-12-31: 11880000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Core Laboratories N.V. · 2020-12-31 Core Laboratories N.V. (esef:724500MDYY5VBSAF5W50) Capital Expenditure: 11880000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-09T10:38:39Z Snapshot: a6d90d4b49a51421669fee8cc686d1999beceda904c5505aad70d76fe9d73fa7 Dimensions: Consolidated View: https://fundies.io/companies/esef/724500MDYY5VBSAF5W50/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11880000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8946365 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 The citation records this snapshot. The page link may show a newer release later.	USD 63.39 million Calculation and evidence 75272000 − 11880000 USD Exact free cash flow: 63392000 USD 2020-01-01 – 2020-12-31: 75272000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 11880000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Core Laboratories N.V. · 2020-12-31 Core Laboratories N.V. (esef:724500MDYY5VBSAF5W50) Free cash flow: 63392000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-09T10:38:39Z Snapshot: a6d90d4b49a51421669fee8cc686d1999beceda904c5505aad70d76fe9d73fa7 Dimensions: Consolidated View: https://fundies.io/companies/esef/724500MDYY5VBSAF5W50?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 75272000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8945259 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 Input fundies:CapitalExpenditure: 11880000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8946365 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 23.44 million Exact value Exact value: 23442000 USD 2021-01-01 – 2021-12-31: 23442000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Core Laboratories N.V. · 2021-12-31 Core Laboratories N.V. (esef:724500MDYY5VBSAF5W50) Net Income: 23442000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-09T10:38:39Z Snapshot: a6d90d4b49a51421669fee8cc686d1999beceda904c5505aad70d76fe9d73fa7 Dimensions: Consolidated View: https://fundies.io/companies/esef/724500MDYY5VBSAF5W50/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 23442000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8822946 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 The citation records this snapshot. The page link may show a newer release later.	USD 52.95 million Exact value Exact value: 52946000 USD 2021-01-01 – 2021-12-31: 52946000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Core Laboratories N.V. · 2021-12-31 Core Laboratories N.V. (esef:724500MDYY5VBSAF5W50) Operating Cash Flow: 52946000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-09T10:38:39Z Snapshot: a6d90d4b49a51421669fee8cc686d1999beceda904c5505aad70d76fe9d73fa7 Dimensions: Consolidated View: https://fundies.io/companies/esef/724500MDYY5VBSAF5W50/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 52946000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8944954 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 The citation records this snapshot. The page link may show a newer release later.	USD 13.54 million Exact value Exact value: 13539000 USD 2021-01-01 – 2021-12-31: 13539000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Core Laboratories N.V. · 2021-12-31 Core Laboratories N.V. (esef:724500MDYY5VBSAF5W50) Capital Expenditure: 13539000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-09T10:38:39Z Snapshot: a6d90d4b49a51421669fee8cc686d1999beceda904c5505aad70d76fe9d73fa7 Dimensions: Consolidated View: https://fundies.io/companies/esef/724500MDYY5VBSAF5W50/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13539000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8945928 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 The citation records this snapshot. The page link may show a newer release later.	USD 39.41 million Calculation and evidence 52946000 − 13539000 USD Exact free cash flow: 39407000 USD 2021-01-01 – 2021-12-31: 52946000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 13539000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Core Laboratories N.V. · 2021-12-31 Core Laboratories N.V. (esef:724500MDYY5VBSAF5W50) Free cash flow: 39407000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-09T10:38:39Z Snapshot: a6d90d4b49a51421669fee8cc686d1999beceda904c5505aad70d76fe9d73fa7 Dimensions: Consolidated View: https://fundies.io/companies/esef/724500MDYY5VBSAF5W50?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 52946000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8944954 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 Input fundies:CapitalExpenditure: 13539000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/724500MDYY5VBSAF5W50/2021-12-31/ESEF/NL/0/CoreLaboratiesNV-2021-12-31.zip#8945928 Filing: 724500MDYY5VBSAF5W50-2021-12-31-ESEF-NL-0 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

1 filings · 125 latest values · 125 originally reported values

Dataset published 2026-11-09. Source filing dates and reporting periods are shown separately.

Identifiers: 724500MDYY5VBSAF5W50, esef:724500MDYY5VBSAF5W50

Core Laboratories N.V.

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2021 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation